Literature DB >> 10760433

The delta-TCP concept: a clinically useful measure of tumor control probability.

B Sanchez-Nieto1, A E Nahum.   

Abstract

PURPOSE: The aim of this article is to provide a quantitative tool to evaluate the influence of the different dose regions in a non-uniformly irradiated tumour upon the probability of controlling that tumor. METHODS AND MATERIALS: First, a method to generate a distribution of the probability of controlling the cells in a voxel (VCP) is explored and found not to be useful. Second, we introduce the concept of delta-TCP, which represents the gain or loss in the overall TCP as a result of each particular bin in a DVH not receiving the prescribed dose (the same concept is applicable to dose cubes or to a fraction of the bin). The delta-TCP method presented here is based on the Poisson TCP model, but any other model could also be used. Third, using this tool, with parameters appropriate to Stage C prostate tumors, the consequences of "cold" and "hot" dose regions have been explored.
RESULTS: We show that TCP is affected by the minimum dose, even if it is delivered to a very small volume (20% dose deficit to 5% of the volume makes the TCP decrease by 18%), and that a hot region may be "wasted" unless the boost is to the bulk of the volume. An example of the application of the delta-TCP concept to a prostate radiotherapy plan is also given.
CONCLUSION: The delta-TCP distribution adds more objective information to the original DVH by enabling the clinician or planner to directly evaluate the effects of a non-uniform dose distribution on local control.

Entities:  

Mesh:

Year:  1999        PMID: 10760433     DOI: 10.1016/s0360-3016(99)00029-2

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  14 in total

1.  The effect of 6 and 15 MV on intensity-modulated radiation therapy prostate cancer treatment: plan evaluation, tumour control probability and normal tissue complication probability analysis, and the theoretical risk of secondary induced malignancies.

Authors:  M Hussein; S Aldridge; T Guerrero Urbano; A Nisbet
Journal:  Br J Radiol       Date:  2011-10-18       Impact factor: 3.039

2.  Robotic radiosurgery as an alternative to brachytherapy for cervical cancer patients.

Authors:  Oliver Neumann; Anne Kluge; Olga Lyubina; Waldemar Wlodarczyk; Ulrich Jahn; Christhardt Köhler; Volker Budach; Markus Kufeld; Simone Marnitz
Journal:  Strahlenther Onkol       Date:  2014-03-04       Impact factor: 3.621

3.  4D radiobiological modelling of the interplay effect in conventionally and hypofractionated lung tumour IMRT.

Authors:  J Selvaraj; J Uzan; C Baker; A Nahum
Journal:  Br J Radiol       Date:  2014-09-24       Impact factor: 3.039

4.  Coverage-based treatment planning to accommodate deformable organ variations in prostate cancer treatment.

Authors:  Huijun Xu; Douglas J Vile; Manju Sharma; J James Gordon; Jeffrey V Siebers
Journal:  Med Phys       Date:  2014-10       Impact factor: 4.071

5.  Two-dimensional imaging of tumour control probabilities and normal tissue complication probabilities.

Authors:  Marta Szlag; Krzysztof Slosarek
Journal:  Rep Pract Oncol Radiother       Date:  2010-04-09

6.  Modelling the interplay between hypoxia and proliferation in radiotherapy tumour response.

Authors:  J Jeong; K I Shoghi; J O Deasy
Journal:  Phys Med Biol       Date:  2013-06-21       Impact factor: 3.609

7.  Vital role of volume and number of needles in HDR brachytherapy (HDR-BT) of prostate cancer.

Authors:  Adam Chicheł; Marek Kanikowski; Janusz Skowronek
Journal:  J Contemp Brachytherapy       Date:  2009-10-08

Review 8.  Can the two mechanisms of tumor cell killing by radiation be exploited for therapeutic gain?

Authors:  J D Chapman
Journal:  J Radiat Res       Date:  2013-10-08       Impact factor: 2.724

9.  Similar-case-based optimization of beam arrangements in stereotactic body radiotherapy for assisting treatment planners.

Authors:  Taiki Magome; Hidetaka Arimura; Yoshiyuki Shioyama; Katsumasa Nakamura; Hiroshi Honda; Hideki Hirata
Journal:  Biomed Res Int       Date:  2013-11-02       Impact factor: 3.411

10.  Impact of dose and sensitivity heterogeneity on TCP.

Authors:  Kristin Wiklund; Iuliana Toma-Dasu; Bengt K Lind
Journal:  Comput Math Methods Med       Date:  2014-05-12       Impact factor: 2.238

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.